Learn more

ARYX THERAPEUTICS INC

Overview
  • Total Patents
    55
About

ARYX THERAPEUTICS INC has a total of 55 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, China and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and computer technology are BISACCHI GREGORY S, FUJIMOTO BROTHERS CO LTD and FYFE MATTHEW COLIN THOR.

Patent filings per year

Chart showing ARYX THERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Druzgala Pascal 37
#2 Becker Cyrus 15
#3 Pfister Jurg R 9
#4 Pascal Druzgala 8
#5 Zhang Xiaoming 7
#6 Cyrus Becker 7
#7 Palme Monica 6
#8 Rubens Courtney 6
#9 Milner Peter G 6
#10 Pang Ponny 6

Latest patents

Publication Filing date Title
WO2010071813A1 AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-α
WO2010062959A1 5-ht4 receptor agonists for treating irritable bowel syndrome and colonic hypersensitivity
AU2008202241A1 Materials and methods for treating hypercholesterolemia
MX2009009535A Dibenzo[b,f][1,4]oxazapine compounds.
WO2007149929A1 Piperidine derivatives for the treatment of gastrointestinal and cns disorders
CN101258151A Synthetic methods and for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
KR20080040645A Antiarrhythmic precursor compounds, methods of synthesis and methods of use
EP1907376A2 Stereoisomeric pyridyl and pyridonyl compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US2006047000A1 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US2005176805A1 Compounds for treatment of cardiac arrhythmia, synthesis, and methods of use
CN101824033A Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
AU2003259188A1 Materials and methods for treating hypercholesterolemia
US6958355B2 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis